These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35336938)

  • 1. Identification of SARS-CoV-2 Spike Palmitoylation Inhibitors That Results in Release of Attenuated Virus with Reduced Infectivity.
    Ramadan AA; Mayilsamy K; McGill AR; Ghosh A; Giulianotti MA; Donow HM; Mohapatra SS; Mohapatra S; Chandran B; Deschenes RJ; Roy A
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-acylation of SARS-CoV-2 spike protein: Mechanistic dissection, in vitro reconstitution and role in viral infectivity.
    Puthenveetil R; Lun CM; Murphy RE; Healy LB; Vilmen G; Christenson ET; Freed EO; Banerjee A
    J Biol Chem; 2021 Oct; 297(4):101112. PubMed ID: 34428449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interactions of ZDHHC5/GOLGA7 with SARS-CoV-2 spike (S) protein and their effects on S protein's subcellular localization, palmitoylation and pseudovirus entry.
    Zeng XT; Yu XX; Cheng W
    Virol J; 2021 Dec; 18(1):257. PubMed ID: 34961524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmitoylation of SARS-CoV-2 S protein is critical for S-mediated syncytia formation and virus entry.
    Li D; Liu Y; Lu Y; Gao S; Zhang L
    J Med Virol; 2022 Jan; 94(1):342-348. PubMed ID: 34528721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Glycosylation and Disulfide Bonding of Wild-Type SARS-CoV-2 Spike Glycoprotein.
    Zhang S; Go EP; Ding H; Anang S; Kappes JC; Desaire H; Sodroski JG
    J Virol; 2022 Feb; 96(3):e0162621. PubMed ID: 34817202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmitoylation of SARS-CoV S protein is necessary for partitioning into detergent-resistant membranes and cell-cell fusion but not interaction with M protein.
    McBride CE; Machamer CE
    Virology; 2010 Sep; 405(1):139-48. PubMed ID: 20580052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion.
    Petit CM; Chouljenko VN; Iyer A; Colgrove R; Farzan M; Knipe DM; Kousoulas KG
    Virology; 2007 Apr; 360(2):264-74. PubMed ID: 17134730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new intracellular targeting motif in the cytoplasmic tail of the spike protein may act as a target to inhibit SARS-CoV-2 assembly.
    Hu L; Tang Y; Mei L; Liang M; Huang J; Wang X; Wu L; Jiang J; Li L; Long F; Xiao J; Tan L; Lu S; Peng T
    Antiviral Res; 2023 Jan; 209():105509. PubMed ID: 36572190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-acylation controls SARS-CoV-2 membrane lipid organization and enhances infectivity.
    Mesquita FS; Abrami L; Sergeeva O; Turelli P; Qing E; Kunz B; Raclot C; Paz Montoya J; Abriata LA; Gallagher T; Dal Peraro M; Trono D; D'Angelo G; van der Goot FG
    Dev Cell; 2021 Oct; 56(20):2790-2807.e8. PubMed ID: 34599882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palmitoylation of SARS-CoV-2 S protein is essential for viral infectivity.
    Wu Z; Zhang Z; Wang X; Zhang J; Ren C; Li Y; Gao L; Liang X; Wang P; Ma C
    Signal Transduct Target Ther; 2021 Jun; 6(1):231. PubMed ID: 34117209
    [No Abstract]   [Full Text] [Related]  

  • 12. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FASN inhibitor TVB-3166 prevents S-acylation of the spike protein of human coronaviruses.
    Mekhail K; Lee M; Sugiyama M; Astori A; St-Germain J; Latreille E; Khosraviani N; Wei K; Li Z; Rini J; Lee WL; Antonescu C; Raught B; Fairn GD
    J Lipid Res; 2022 Sep; 63(9):100256. PubMed ID: 35921881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains.
    Qing E; Kicmal T; Kumar B; Hawkins GM; Timm E; Perlman S; Gallagher T
    mBio; 2021 Aug; 12(4):e0159021. PubMed ID: 34340537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-Soluble NSF Attachment Protein Prevents the Cleavage of the SARS-CoV-2 Spike Protein by Functioning as an Interferon-Upregulated Furin Inhibitor.
    Wang J; Luo J; Wen Z; Wang X; Shuai L; Zhong G; Wang C; Sun Z; Chen W; Ge J; Liu R; Wang X; Bu Z
    mBio; 2022 Feb; 13(1):e0244321. PubMed ID: 35012335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors.
    Park SB; Irvin P; Hu Z; Khan M; Hu X; Zeng Q; Chen C; Xu M; Leek M; Zang R; Case JB; Zheng W; Ding S; Liang TJ
    mBio; 2022 Feb; 13(1):e0323821. PubMed ID: 35012356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "LLQY" Motif on SARS-CoV-2 Spike Protein Affects S Incorporation into Virus Particles.
    Du S; Xu W; Wang Y; Li L; Hao P; Tian M; Wang M; Li T; Wu S; Liu Q; Bai J; Qu X; Jin N; Zhou B; Liao M; Li C
    J Virol; 2022 Mar; 96(6):e0189721. PubMed ID: 35045269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation and S-palmitoylation regulate SARS-CoV-2 spike protein intracellular trafficking.
    Tien CF; Tsai WT; Chen CH; Chou HJ; Zhang MM; Lin JJ; Lin EJ; Dai SS; Ping YH; Yu CY; Kuo YP; Tsai WH; Chen HW; Yu GY
    iScience; 2022 Aug; 25(8):104709. PubMed ID: 35813875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence.
    Riccio A; Santopolo S; Rossi A; Piacentini S; Rossignol JF; Santoro MG
    Cell Mol Life Sci; 2022 Apr; 79(5):227. PubMed ID: 35391601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity.
    Pal D
    J Struct Biol; 2021 Jun; 213(2):107713. PubMed ID: 33662570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.